Gilead initiated with an Outperform at Wolfe Research
Wolfe Research initiated coverage of Gilead (GILD) with an Outperform rating and $110 price target Published first on TheFly – the ...
Gilead, Vertex initiated as new big biotech buys at Citi
Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.
Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet
According to the average brokerage recommendation (ABR), one should invest in Gilead (GILD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' ...
Ligand to Present at Stifel 2024 Healthcare Conference
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief ...
kalkinemedia16h
Gilead Sciences (NASDAQ: GILD) Announces Pricing of $3.5 Billion...
Key Highlights:,Gilead Sciences successfully raises $3.5 billion through a public offering of senior unsecured notes.,Debt ...
jacobin2d
Transgender Politics Didn’t Have to End Up Here
Democratic Party leaders and their donors bear responsibility for the increasingly widespread view of trans rights as ...
Yahoo2d
GILD or VRTX: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Gilead Sciences (GILD) or Vertex Pharmaceuticals (VRTX). But which of these two stocks ...
Gilead downgraded to Hold from Buy at Maxim
Maxim downgraded Gilead (GILD) to Hold from Buy. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...